The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Osteopontin is a ligand for the α4β1 integrin
Abstract
Recent work has shown that osteopontin expression is upregulated at sites of cardiovascular injury. It has been hypothesized that osteopontin provides an adhesive matrix for endothelial and smooth muscle cells during remodeling of the vascular wall following injury. Osteopontin has also been found to be synthesized by monocytes and macrophages within injury sites. Here, we present data showing that osteopontin can promote leukocyte adhesion through the α4β1 integrin. In the presence of physiologic concentrations of Mg2+ and Ca2+, osteopontin purified from bovine milk promoted cell-substrate adhesion of HL-60 and Ramos cells, two model leukocyte cell lines. As with other adhesive ligands, adhesion to osteopontin required leukocyte activation. Under these conditions, no adhesion to control substrates such as bovine serum albumin was observed. Leukocyte adhesion was inhibited by anti-integrin antibodies directed at either the α4 or β1 integrin subunits but not by control antibodies directed to other integrins. Further adhesion experiments revealed that leukocyte binding to osteopontin was completely inhibited by an α4β1-binding peptide containing the leucine-aspartate-valine (LDV) sequence, while a control, non-binding peptide containing leucine-glutamate-valine (LEV) had minimal effects. Affinity chromatography using either surface labeled HL-60 or Ramos cell extracts revealed that the α4β1 integrin specifically bound to osteopontin. Immunoprecipitation of eluted fractions from these columns positively identified the α4β1 integrin. In order to localize potential α4β1-binding sites within osteopontin, the protein was proteolytically cleaved with thrombin. A 30 kDa N-terminal osteopontin fragment purified using fast protein liquid chromatography promoted α4β1 dependent leukocyte adhesion in a manner similar to that of the intact protein. These data collectively demonstrate that the α4β1 integrin is a new adhesion receptor for osteopontin and that an α4β1 binding site exists in the NH2-terminal thrombin fragment of osteopontin.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ross, F. P., Chappel, J., Alvarez, J. I., Sander, D., Butler, W. T., Farach-Carson, M. C., Mintz, K. A., Robey, P. G., Teitelbaum, S. L., & Cheresh, D. A. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98430-9 · Cited by 537
Cited by
A Randomized, Placebo-Controlled Trial of Natalizumab for Relapsing Multiple Sclerosis
Polman, C. H., O'Connor, P. W., Havrdova, E., Hutchinson, M., Kappos, L., Miller, D. H., Phillips, J. T., Lublin, F. D., Giovannoni, G., Wajgt, A., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa044397 · Cited by 3,386
Sodek, J., Ganss, B., & McKee, M. D. (2000) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/10454411000110030101 · Cited by 993
Nilsson, S. K., Johnston, H. M., Whitty, G. A., Williams, B., Webb, R. J., Denhardt, D. T., Bertoncello, I., Bendall, L. J., Simmons, P. J., & Haylock, D. N. (2005) · Blood · doi:10.1182/blood-2004-11-4422 · Cited by 806
Stier, S., Ko, Y., Forkert, R., Lutz, C., Neuhaus, T., Grünewald, E., Cheng, T., Dombkowski, D., Calvi, L. M., Rittling, S. R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041992 · Cited by 714
Osteopontin: role in immune regulation and stress responses
Wang, K. X., & Denhardt, D. T. (2008) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2008.08.001 · Cited by 669
Osteopontin: A Multifunctional Molecule Regulating Chronic Inflammation and Vascular Disease
Scatena, M., Liaw, L., & Giachelli, C. M. (2007) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.107.144824 · Cited by 644
Osteopontin: a versatile regulator of inflammation and biomineralization
Giachelli, C. M., & Steitz, S. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00108-6 · Cited by 583
Davis, G. E., Bayless, K. J., Davis, M. J., & Meininger, G. A. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65020-1 · Cited by 452
Self-citationOsteopontin expression and function: Role in bone remodeling
Denhardt, D. T., & Noda, M. (1998) · Journal of Cellular Biochemistry · doi:10.1002/(sici)1097-4644(1998)72:30/31+<92::aid-jcb13>3.0.co;2-a · Cited by 440
Revisiting the matricellular concept
Murphy-Ullrich, J. E., & Sage, E. H. (2014) · Matrix Biology · doi:10.1016/j.matbio.2014.07.005 · Cited by 392
The role of Osteopontin in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2004) · Journal of Surgical Research · doi:10.1016/j.jss.2004.03.028 · Cited by 365
Expression, roles, receptors, and regulation of osteopontin in the kidney
Xie, Y., Sakatsume, M., Nishi, S., Narita, I., Arakawa, M., & Gejyo, F. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00032.x · Cited by 361
Osteopontin: a key cytokine in cell‐mediated and granulomatous inflammation
O'Regan, A., & Berman, J. S. (2000) · International Journal of Experimental Pathology · doi:10.1046/j.1365-2613.2000.00163.x · Cited by 357
Role of Osteopontin in Cellular Signaling and Toxicant Injury
Denhardt, D. T., Giachelli, C. M., & Rittling, S. R. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.723 · Cited by 349
Osteopontin: Roles in Implantation and Placentation1
Johnson, G. A., Burghardt, R. C., Bazer, F. W., & Spencer, T. E. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.103.020651 · Cited by 338
Osteopontin: regulation in tumor metastasis
Wai, P. Y., & Kuo, P. C. (2008) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9104-9 · Cited by 321
Anti-α4 integrin therapy for multiple sclerosis: Mechanisms and rationale
Rice, G. P. A., Hartung, H.-P., & Calabresi, P. A. (2005) · Neurology · doi:10.1212/01.wnl.0000158329.30470.d0 · Cited by 305
Yokosaki, Y., Matsuura, N., Sasaki, T., Murakami, I., Schneider, H., Higashiyama, S., Saitoh, Y., Yamakido, M., Taooka, Y., & Sheppard, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.51.36328 · Cited by 305
Osteopontin in Bone Metabolism and Bone Diseases
Si, J., Wang, C., Zhang, D., Wang, B., Hou, W., & Zhou, Y. (2020) · Medical Science Monitor · doi:10.12659/msm.919159 · Cited by 301
Pig blastocyst–uterine interactions
Bazer, F. W., & Johnson, G. A. (2014) · Differentiation · doi:10.1016/j.diff.2013.11.005 · Cited by 291
The metastasis gene osteopontin: a candidate target for cancer therapy
Weber, G. F. (2001) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(01)00037-3 · Cited by 286
Adhesion receptors of vascular smooth muscle cells and their functions
Moiseeva, E. (2001) · Cardiovascular Research · doi:10.1016/s0008-6363(01)00399-6 · Cited by 282
Vetrone, S. A., Montecino-Rodriguez, E., Kudryashova, E., Kramerova, I., Hoffman, E. P., Liu, S. D., Miceli, M. C., & Spencer, M. J. (2009) · Journal of Clinical Investigation · doi:10.1172/jci37662 · Cited by 279
Taooka, Y., Chen, J., Yednock, T., & Sheppard, D. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.2.413 · Cited by 261
Walsh, S., Jordan, G. R., Jefferiss, C., Stewart, K., & Beresford, J. N. (2001) · Rheumatology · doi:10.1093/rheumatology/40.1.74 · Cited by 192
Integrin Signaling Shaping BTK-Inhibitor Resistance
Polcik, L., Dannewitz Prosseda, S., Pozzo, F., Zucchetto, A., Gattei, V., & Hartmann, T. N. (2022) · Cells · doi:10.3390/cells11142235 · Cited by 15
Metadata
- Authors
- Bayless, K. J., Meininger, G. A., Scholtz, J. M., & Davis, G. E.
- Venue
- Journal of Cell Science
- Publisher
- The Company of Biologists
- Published
- 1998-05-01
- Volume
- 111
- Issue
- 9
- Pages
- 1165-1174
- ISSN
- 0021-9533 (ISSN-L)
- 1477-9137
- OpenAlex
- W1839610592
- Cited by
- 214
- References
- 1
- FWCI
- 9.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.